RRD News and Press, R.R. Donnelley & Sons Company From 05/02/21

Higher demand for medical kits and increased direct-to-consumer sales will affect RRD’s top line favorably in 2021. However, the demand loss due to lower marketing spend by the clients, and the end of the Census project is likely to mitigate the revenue growth in Q2 2021. T...

Gainers: ShiftPixy (PIXY) +18%. MYR Group (MYRG) +10%. Hydrofarm (HYFM) +10%. Sharps Compliance (SMED) +8%. The L.S. Starrett (SCX) +8%.Losers: Navios Maritime (NM) -9%. Columbus McKinnon (CMCO) -8%. Triton International (TRTN) -8%. R. R. Donnelley & Sons (RRD) -7...

Image source: The Motley Fool. R.R. Donnelley & Sons (NYSE: RRD) Q1 2021 Earnings Call Apr 28, 2021 , 11:00 a.m. ET Operator Continue reading For further details see: R.R. Donnelley & Sons (RRD) Q1 2021 Earnings Call Transcript

R. R. Donnelley & Sons Company (RRD) Q1 2021 Earnings Conference Call Apr 28, 2021, 11:00 AM ET Company Participants Johan Nystedt - Senior Vice President, Finance Dan Knotts - President and Chief Executive Officer Terry Peterson - Chief Financial Officer Conference Call Participants Char...

Our job as #investors is to pay attention to the #stocks we own.  Part of that involves looking at the #fundamentals, but half of the disclosure comes from looking at price action. The R.r. Donnelley & Sons Co (NYSE: RRD) data table below can help you with price action,...

Gainers: Brooklyn ImmunoTherapeutics (BTX) +44%.Uxin (UXIN) +25%.Ashford Hospitality Trust (AHT) +24%.Boxlight (BOXL) +21%.ADMA Biologics (ADMA) +18%.Clover Health Investments (CLOV) +16%.Unitil (UTL) +15%.Pitney Bowes (PBI) +15%.ClearSign Technologies (CLIR) +15%.Microvision (MVIS) ...

Shares of R.R. Donnelley & Sons (NYSE: RRD) have been moving higher of late on optimism that the 157-year-old printing company's push to revamp the business was beginning to take hold. But first-quarter earnings came in well below expectations, causing the stock to fall by a...

Protalix BioTherapeutics (PLX) -43% on FDA rejection of experimental therapy for Fabry disease.Benitec Biopharma (BNTC) -22% after secures $13M capital via equity offering.Urban Tea (MYT) -13% on 1H earnings releasePinterest (PINS) -12% on Q1 earnings releas...

R.R. Donnelley & Sons (RRD) down 7.3% in pre-market trading, after reporting Q1 revenue of $1.17B down 4.1% Y/Y; and adj. income from continuing operations of $37.4M (-25.8% Y/Y).Q1 Gross margin decline by 130 bps to 19.1%; and operating margin declined b 60 ...

The following slide deck was published by R. R. Donnelley & Sons Company in conjunction with their 2021 Q1 earnings call. For further details see: R. R. Donnelley & Sons Company 2021 Q1 - Results - Earnings Call Presentation